Colombian Company VaxThera Receives Key Patent Grant for Locally Developed COVID-19 Vaccine
Medellín, julio de 2024. VaxThera, a Colombian biotechnology company focused on developing vaccines and biologics that contribute to the health sovereignty of Colombia and the region, announced that the United States Patent and Trademark Office (USPTO) has granted a patent for its coronavirus vaccine. The patent covers a mosaic protein designed to provide broad protection […]
The Ministry of Health and Social Protection of Colombia and the National Health Institute of Colombia sign an agreement with VaxThera to strengthen health sovereignty
The Special Framework Agreement for Scientific and Technological Cooperation signed between Ministry of Health and Social Protection of Colombia, the National Health Institute of Colombia (INS), and VaxThera represents an innovation model that seeks to join efforts to strengthen local capacities in terms of health sovereignty. Medellín, February 28th, 2025 – As part of the […]
VaxThera and Seguros SURA Launch Colombia’s Largest Regional Program to Prevent HPV Associated Cancer
Medellín, September 2025. In Colombia, cervical cancer is the leading cause of cancer-related death among women aged 20 to 35, largely driven by Human Papillomavirus (HPV) infection. This alarming reality exists within a regional context in which 16.1% of women in Latin America are living with chronic HPV infection, compared with a global average of […]
